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This study was conducted to evaluate the potency of the
newly prepared germanium L-cysteine a-tocopherol com-
plex [germanium dichloro tetrakis (L-cysteinyl-a-tocopher-
ol amide) dichloride] as a protective agent against g-irra-
diation-induced free radicals production and liver toxicity.
Male Swiss albino rats were injected intraperitoneally with
the germanium complex in a concentration of 75 mg kg–1
body mass per dose, for 6 successive doses, last dose ad-
ministered twenty minutes pre-exposure to a single dose
of whole body g-irradiation of 6.5 Gy. Lipid peroxidation
(LPx), nitric oxide (NO), glutathione (GSH) levels, and ac-
tivity of the antioxidant enzymes glutathione peroxidase
(GPx), superoxide dismutase (SOD), and catalase (CAT)
were estimated in blood and liver. Blood total protein,
cholesterol, triglyceride and a-tocopherol content were esti-
mated as well. The results revealed that administration of
germanium complex pre-irradiation resulted in signifi-
cant (p < 0.001) improvement compared to the irradiated
group in the level of hepatic and blood LPx. Hepatic GSH
revealed a significant increase (p < 0.001), while its level
showed no significant variation in blood. Also, the level
of NO in blood and liver increased significantly (p < 0.001).
On the other hand, pretreatment with the germanium com-
plex normalized the activities of SOD, GPx and CAT in
blood and liver when compared to the irradiated group.
The study also documents a marked decrease in a blood
triglyceride and cholesterol (p < 0.001) and a significant
increase (p < 0.001) of a-tocopherol and total protein con-
tents in blood. These biochemical changes were associated
with marked improvement of histological status. There-
fore, the germanium L-cysteine a-tocopherol complex may
be a good candidate for ameliorating the changes induced
by irradiation, which indicates the beneficial radio-pro-
tective role of this antioxidant agent.
Keywords: germanium L-cysteine a-tocopherol, g-irradia-
tion, liver, antioxidant enzymes
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There is growing evidence that radiation injury to living cells is, to a large extent,
due to oxidative stress (1). The interaction of ionizing radiation with living cells induces
a variety of reaction products and a complex chain reaction in which many macromo-
lecules and their degradation products participate. Major biomarkers of oxidative dam-
age to living cells are lipid peroxidation (LPx) products, DNA-hydroxylation and pro-
tein hydroxylation products (2). Efficient defense and repair mechanisms exist in living
cells to protect against oxidant species (3). The antioxidative defense system is composed
of methods to: transfer sensitive material to compartments better protected from the ac-
tion of reactive species, complex transition metals, a potential source of electrons, thereby
rendering them unreactive, inhibit vulnerable processes such as DNA replication, repair
damaged molecules, initiate apoptosis, and, possibly most important considering the lia-
bility to internal and external modifying factors, activate antioxidant enzymes, and fi-
nally use a variety of direct free radical scavengers (4). Enzymes involved in antioxidative
defense particularly well documented are superoxide dismutase, glutathione peroxidas-
es and catalase (2). There is need for non-toxic and inexpensive drugs for clinical radia-
tion protection. Antioxidant agents may help protect against chemically induced or radi-
ation induced toxicity in rats (5). Previous studies have indicated that some commonly
used antioxidants of plant origin include vitamin E, vitamin C, selenium, phenolic com-
pounds, carotenoids and flavonoids (6).
Numerous biochemical compounds such as cysteine (7), germanium (8) and a-to-
copherol (9) have been used individually to target oxygen and oxygen free-radicals in
attempts to reduce radiation-induced damage. Various studies have suggested that ger-
manium compounds may have a protective effect against liver injury and similar oxy-
gen-enriching properties and rigorously documented antioxidant effects (8, 10). Ge-132
administered to patients undergoing radiotherapy for cancer offers protection against
radiation-induced killing of white and red blood cells (10). Precise mechanisms describ-
ing how organic germanium can protect cells from radiation damage have not been elu-
cidated. However, according to Asai (11), atoms of Ge-132 securely fasten to red blood
cells and shelter these cells from oncoming electrons by diverting them around the atom.
It is postulated that organic germanium could have affinity for blood cells; possibly ow-
ing to electronic attraction due to germanium’s extended network shape and its ability
to conduct electrons efficiently (10). a-Tocopherol is the most important lipid-soluble chain-
-breaking antioxidant in tissues and blood. This vitamin might protect cellular compo-
nents against peroxidation damage via the free radical scavenging mechanism (9). In ad-
dition, cysteine is a potent antioxidant that has been shown to protect from oxidative
stress. In particular, cysteine is known to increase the intracellular stores of glutathione,
thereby enhancing endogenous antioxidant levels (12).
Few studies have observed the important role of some metals and/or their orga-
nocomplexes against detrimental effects of ionizing radiation. The present study was
undertaken to investigate the possible radioprotective role of the prepared germanium
L-cysteine a-tocopherol complex of the formula Ge(C32H50NO3S)4Cl4 against whole body
g-irradiation induced alteration in the antioxidant system in vivo.
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EXPERIMENTAL
Chemicals
All chemicals and reagents used were of the highest purity available and purchased
from either Merck (Germany) or Sigma-Aldrich Chemie (Germany). Kits for total pro-
tein, cholesterol and triglyceride were supplied by Biocon Company (Germany).
Preparation of the germanium L-cysteine a-tocopherol complex
L-cysteine (0.1 mol) and 0.1 mol of a-tocopherol in 25 mL of toluene were reacted in
the presence of 1 mL p-toluene sulfonic acid as catalyst and refluxed until a stoichio-
metric amount of water was recovered in a Dean-stark trap. The product was then con-
centrated by rotator evaporation and three times recrystallized from acetone. Germanium
tetrachloride (0.1 mol) was added slowly to L-cysteinyl-a-tocopherol (0.4 mol) dissolved
in 200 mL acetone. The reaction mixture was heated to about 90 °C and poured into an
evaporating dish to let the acetone evaporate until white crystals of the quaternary ammo-
nium compound were formed. As shown in Table I and Fig. 1, the structure of the ob-
tained compound germanium dichloro tetrakis (L-cysteinyl-a-tocopherol amide) dichlo-
ride was confirmed by elemental analysis on a Vario EL Elementar (Elementar Americas,
USA), Fourier transform infrared FT-IR using KBr disks (ATI Mattson Genesis, USA), and
1H NMR spectra Varian Gemini-spectrophotometer (Camberage Isotope Laboratory, UK)
in DMSO. The melting point of the synthesized compound was determined in open capil-
lary tubes (Toshniwal Electric, Japan).
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Table I. Physicochemical and spectral analysis of the germanium L-cysteine a-tocopherol complex
Elemental analysis
C H N S Ge
Calculated (%) 67.09 3.39 2.79 6.37 3.64
Found (%) 67.64 3.97 3.05 6.64 3.31
IR
Function group NH SH CH2 CH3 C=O CH Ge-N
 (cm–1) 3328 2358 1489 1413 1724 1332 635
1H NMR
Function group CH3 CH3-Ph CH2 CH SH NH
 (ppm) 2.35 1.53 1.30 3.77 1.50 2.00
Molecular formula (Mr) Ge(C32H50NO3S)4Cl4
(2329.69)
Melting point (°C) > 300
Animals and in vivo experiments
Animal care and handling complied with the guidelines set by the World Health
Organization, Geneva, Switzerland. Male Swiss albino rats weighing 100–120 g (6–8 weeks)
obtained from the Egyptian Organization for Biological Products and Vaccines, Giza (Egypt),
were used in this study. Rats were housed at a constant temperature (24 ± 2 °C) with al-
ternating 12 hours light and dark cycles and fed standard laboratory food and water ad
libitum.
Doses determination
In order to determine a non toxic dose of germanium L-cysteine a-tocopherol, the
doses that caused acute toxicity were identified. Hence, adult male Swiss albino rats were
subjected to a series of different concentrations ranging from 15 to 150 mg kg–1 body
mass dissolved in sterile saline. These concentrations were then injected i.p. into 10 rats;
each concentration and each dose were repeated six times. Acute toxicity doses were cal-
culated using probability analysis according to Ghosh (13). Thus a non toxic dose of 75
mg kg–1 body mass was chosen for the subsequent study in an in vivo radioprotection
experiment. Germanium L-cysteine a-tocopherol was dissolved in 0.9% saline and ad-
ministered to rats i.p. in a concentration of 75 mg kg–1 body mass per dose for 6 succes-
sive doses based on the preliminary study. Last dose was administered twenty minutes
before radiation exposure.
At the beginning of the experiment, rats were divided into four groups of 8 rats
each. The first was the control group treated i.p. with 0.9% saline, the second group was
exposed to g-irradiation, the third group was treated with germanium L-cysteine a-toco-
pherol compound alone, the fourth group was treated with germanium L-cysteine a-to-
copherol pre-exposed to g-irradiation.
Irradiation
Whole body g-irradiation was performed at the National Centre for Radiation Re-
search and Technology, Atomic Energy Authority (NCRRT), Cairo, Egypt, using caesium-
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Fig. 1. Chemical structure of germanium, dichloro tetrakis
(L-cysteinyl-a-tocopherol amide) dichloride.
-137 in a Gamma cell-40 Irradiator (Atomic Energy of Canada Limited, Canada). Ani-
mals were irradiated at an acute single dose level of 6.5 Gy delivered at a dose rate of
0.65 Gy min–1.
Samples collection
Samples were collected after 7 days post-irradiation from 16 hours fasting animals.
Whole blood was collected by heart puncture after light anesthesia using heparinized
syringes. Part of whole blood was used for determination of lipid peroxidation (LPx), ni-
tric oxide (NO), glutathione (GSH) levels, and activity of the antioxidant scavenger en-
zymes glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT);
blood total protein, cholesterol, triglyceride and a-tocopherol contents were also estima-
ted. Liver was dissected out and divided into two parts. One part was used for assays of
GSH, CAT, GPx, SOD, LPx, and NO. Liver homogenates were prepared in ice-cold phos-
phate buffer (0.1 mol L–1, pH 7.4) using a Potter-Elvehjem homogenizer (Labimex, Po-
land) to give a 10% homogenate. The other part of the liver was used for a histopa-
thological study by fixation in 10% formalin in saline, then embedded in paraffin wax,
serially sectioned and stained according to Conn et al. (14) using a standard hematoxylin
and eosin method.
Analytical procedures
LPx in blood and tissues was ascertained by the formation of thiobarbituric acid re-
active substances (TBARS) and measured as described by Conrad et al. (15). GSH con-
tent was determined according to Beutler et al. (16). SOD, CAT, and GPx activities were
quantitated according to Minami and Yoshikawa (17), Johansson and Borg (18), Paglia
and Valentine (19), respectively. NO was determined according to the methods of Mosha-
ge et al. (20). Total protein, cholesterol and triglycerides contents were assessed spectro-
photometrically using reagent kits obtained from Biocon Company (Germany). Determi-
nation of a-tocopherol was carried out according to the method of Baker and Frank (21).
Statistical analysis
Student’s t-test was used for data evaluation. The data were expressed as mean ±
standard error of the mean (SEM).
RESULTS AND DISCUSSION
In the present study, whole body g-irradiation strongly initiates the process of LPx as
indicated by the formation of TBARS in both blood and liver, reduction in the level of
GSH and increased formation of NO, as shown in Table II. The results for LPx show that,
g-irradiated rats exhibited a significant (p < 0.001) increase in TBARS level in liver (from
129.65 ± 9.62 to 176.63 ± 7.08 µg g–1) and in blood (from 32.25 ± 1.86 to 49.81 ± 4.04 µg mL–1)
as compared to the control. Administration of germanium L-cysteine a-tocopherol pre-irra-
diation significantly decreased (p < 0.001) the level of TBARS in liver to 140.62 ± 9.56 µg g–1
5
M. M. Ali et al.: Role of germanium L-cysteine a-tocopherol complex as stimulator of some antioxidant defense systems in gamma-
irradiated rats, Acta Pharm. 57 (2007) 1–12.
and in blood to 39.92 ± 4.16 µg mL–1 when compared to the irradiated group. In addition,
g-irradiation caused a significant decrease in the GSH level (p < 0.001) compared to the
normal group; the level of GSH in both blood and hepatic tissue decreased from 1.09 ± 0.12
to 0.78 ± 0.09 µg g–1 in liver and from 51.38 ± 3.38 to 41.70 ± 4.56 µg mL–1 in blood. Treat-
ment with germanium L-cysteine a-tocopherol before radiation significantly improve (p <
0.001) the hepatic GSH level compared to the irradiated group to 1.37 ± 0.13 µg g–1, while
blood GSH level showed no significant variation. Bump et al. (22) reported that GSH is a
versatile protector and executes its radioprotective function through free-radical sca-
venging, restoration of the damaged molecules by hydrogen donation, reduction of per-
oxides, and maintenance of protein thiols in the reduced state. Further, lower depletion
of blood and liver GSH levels in irradiated animals might have been due to higher GSH
availability, which enhanced the capability of cells to cope with the free radicals gener-
ated by radiation. The significant reduction in liver GSH due to radiation could be due
to an enhanced utilization of the antioxidant system during detoxification of the free ra-
dicals generated by radiation accompanied, with depletion of glutathione with enhanc-
ed lipid peroxidation (6).
The results of NO in blood and hepatic tissue for different studied groups show that
in g-irradiated group the NO level exhibited a significant (p < 0.001) increase as com-
pared with control, the level of NO in liver increased from 1.32 ± 0.10 to 1.88 ± 0.06 µg
g–1 and in blood from 9.67 ± 0.67 to 24.25 ± 1.89 µg mL–1. When the animals were pro-
tected before radiation the level of NO was restored to the control level; normaly it was
significantly (p < 0.001) reduced as compared to the irradiated group (liver NO level de-
creased to 1.48 ± 0.06 µg g–1 and blood level dropped to 13.50 ± 1.75 µg mL–1). The in-
creased production of NO in the irradiated group is due to induction of NO synthase en-
zyme, which is considered to be absent under physiological conditions and induced by
6
M. M. Ali et al.: Role of germanium L-cysteine a-tocopherol complex as stimulator of some antioxidant defense systems in gamma-
irradiated rats, Acta Pharm. 57 (2007) 1–12.
Table II. The effect of germanium L-cysteine a-tocopherol on blood reduced glutathione (GSH), nitric
oxide (NO), and lipid peroxidation (TBARS) levels, catalase (CAT), superoxide dismutase (SOD) and
glutathione peroxidase (GPx) activitya













































































































































a Each value represents mean ± SEM (n = 8).
b Significantly different from control group (p < 0.001), c Significantly different from irradiated group (p < 0.001).
radiation (23). Superoxide anion (O2–) can attack NO to form peroxynitrite (ONOO–)
anion, which may oxidize many biological molecules including sulfhydryls (such as glu-
tathione), iron sulfur centers and lipids (24).
The effect of germanium L-cysteine a-tocopherol on the blood and hepatic antioxi-
dant enzymes CAT, SOD and GPx activity of rats exposed to g-irradiation is shown in
Table II. As compared to the control group, the irradiated group revealed significant de-
cline (p < 0.001) in activities of antioxidant enzymes SOD and GPx in blood and liver.
Hepatic SOD decreased from 43.30 ± 0.57 to 39.03 ± 0.28 nmol min–1 g–1 and in blood
from 1.07 ± 0.07 to 0.38 ± 0.01 nmol min–1 mL–1; hepatic GPx decreased from 25.21 ± 2.48
to 7.75 ± 1.32 mmol min–1 g–1 and in blood from 11.02 ± 1.47 to 5.61 ± 0.45 mmol min–1
mL–1. Hepatic CAT activity showed a significant decrease (p < 0.001) from 16.27 ± 1.42 to
8.76 ± 1.22 mmol min–1 g–1 while its activity was not significantly changed in blood. On the
other hand, the pretreatment with germanium L-cysteine a-tocopherol normalized the
activities of CAT, SOD, and GPx in blood and liver compared to the irradiated group:
the activity of SOD in liver increased back to 48.64 ± 0.08 nmol min–1 g–1 and to 0.66 ±
0.03 nmol min–1 mL–1 in blood, hepatic GPx increased to 24.01 ± 2.76 mmol min–1 g–1 and
to 7.72 ± 0.87 mmol min–1 mL–1 in blood, hepatic CAT increased to 19.76 ± 1.21 mmol
min–1 g–1 and to 11.23 ± 1.19 mmol min–1 mL–1 in blood. Oliinyk et al. (25) mentioned
that the inhibition of antioxidant systems in blood and tissues of animals is accompa-
nied by an increase in lipid peroxide products after irradiation exposure. Also, Ueda et
al. (26) mentioned that when the oxidative damage is extreme as a result of irradiation,
ROS scavenging enzymes are degraded. In support of these results, we found a decline
in GPx in liver of rats exposed to irradiation. It is hypothesized that the enzyme inacti-
vating action of ROS or lipid peroxides induced by irradiation can overcome enzyme
synthesis capacity. Also, the decline in SOD activity recorded in mice exposed to radia-
tion may be due to the loss of mitochondria, which leads to a decrease in total MnSOD acti-
vity in different tissues of rats (26). Pretreatment with the germanium complex revealed
improvement in the activities of antioxidant enzymes, which can be explained by the
fact that germanium can enhance the activities of catalase and SOD and inhibit lipid
peroxidation in the liver of g-irradiated mice (27).
Fig. 2 shows that the levels of serum a-tocopherol and total protein in rats exposed
to whole body g-irradiation declined markedly (p < 0.001) compared to the control group;
the level of blood a-tocopherol decreased from 4.34 ± 0.24 to 3.48 ± 0.23 µg per 100 mL
and the level of blood total protein decreased from 5.57 ± 0.19 to 4.12 ± 0.28 mg per 100
mL. On the other hand, pretreatment with the germanium L-cysteine a-tocopherol com-
plex prior to irradiation caused significant elevation (p < 0.001) in the level of a-toco-
pherol and total protein compared to the irradiated group up to 4.63 ± 0.20 µg per 100
mL and to 5.25 ± 0.18 mg per 100 mL, respectively. g-Irradiation can damage or inacti-
vate proteins by two different mechanisms. First, it can rapture the covalent bonds in
target protein molecules as a direct result of a photon depositing energy into the mole-
cule. Second, it can act indirectly, like with a water molecule, producing free radicals
and other non-radical reactive oxygen species that are in turn responsible for most (99.9%)
of the protein damage (28). In addition, the depletion in the vitamin E level can be ex-
plained by the fact that vitamin E is a natural component of cell membranes; it reacts
quickly with peroxyl radicals and forms a tocopheroxyl radical, i.e., a sacrificial mole-
cule with which the peroxyl radicals preferentially react, rather than with biological mo-
lecules, thus preventing damage to cell structures (29).
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Blood cholesterol and triglyceride levels in rats exposed to g-irradiation were signif-
icantly increased (p < 0.001) compared to the control group; the level increased from
174.25 ± 4.61 to 227.50 ± 4.65 mg per 100 mL and from 120.50 ± 5.78 to 150.00 ± 6.44 mg
per 100 mL, respectively. However in the group treated with germanium L-cysteine a-
-tocopherol prior to irradiation, both cholesterol and triglyceride values recorded a sig-
nificant decrease (p < 0.001) compared to the irradiated group, normally to 190.75 ± 6.41
mg per 100 mL and to 135.00 ± 4.94 mg per 100 mL, respectively. Significant elevation of
total cholesterol in plasma of irradiated animals was explained by Bok et al. (30), who
mentioned that irradiation increases activation of HMG-CoA reductase enzyme, the key
regulatory enzyme in the reaction of the cholesterol synthesis process. The increase in
plasma triglycerides in rats exposed to g-irradiation may be attributed to inhibition of
the activity of lipoprotein lipase. This result was consistent with the observation of Sed-
lakova et al. (31), who mentioned that lipoprotein lipase activity decreases post irradia-
tion exposure in adipose tissues giving rise to hypertriglyceridemia.
Light microscopic examinations of liver sections of control animals exhibited nor-
mal constructions (Fig. 3a) while liver sections of rats exposed to g-irradiation showed
liver fibrosis and necrosis with mononuclear leucocytic inflammatory cells, infiltrating
the dilated portal vein in the portal area associated with proliferation of diffuse Kupffer
cells. Liver section exhibited tissue degeneration and lymphocyte infiltration, and vas-
cular degeneration of the hepatocytes (Fig. 3b). In contrast, the irradiated animals pre-
treated with germanium L-cysteine a-tocopherol showed regeneration and amelioration
of the hepatocytes to the normal structure (Fig. 3d). Furthermore, the microscopic struc-
ture of hepatic cells in the group of rats treated with germanium L-cysteine a-tocopherol
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Fig. 2. The effect of germanium L-cysteine a-tocopherol complex on the level of blood a-tocopherol,
total protein, cholesterol and triglycerides of rats exposed to g-irradiation (mean ± SEM, n = 8). a Sig-
nificantly different from control group; b from irradiated group (p < 0.001).
alone showed the normal shape like the control hepatic cells (Fig. 3c). This finding is
supported by several authors. Rodemann and Bamberg (32) reported that fibrosis is a
common sequel of both cancer treatment by radiotherapy and accidental irradiation, which
has been described for many tissues, including skin, lung, heart and liver. The underly-
ing mechanisms of the radiation-induced fibrosis can be seen as a multicellular process
involving various interacting cell systems in the target organ, resulting in the fibrotic
phenotype of the fibroblast/fibrocyte cell system. Germanium L-cysteine a-tocopherol
complex exerts a radical scavenging effect and can prevent radical generation immedi-
ately after irradiation, probably by inhibiting the chain reaction of membrane lipid pero-
xidation that follows, and thus protect membrane lipids from peroxidation damage. This
effect is also confirmed by improvement in the histological changes in the group of rats
treated with the germanium L-cysteine a-tocopherol complex pre-irradiation, as com-
pared to the irradiated group.
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Fig. 3. The hepatoprotective effect of germanium L-cysteine a-tocopherol on the histopathological
changes resulting from the whole body exposure of rats to g-irradiation. Liver sections were stained
with hematoxylin and eosin (original magnification 400x). a) control rat liver showing normal ar-
chitecture; b) irradiated group showing liver fibrosis and necrosis with mononuclear leucocytic in-
flammatory cells, cellular infiltration in portal area associated with proliferation of diffuse Kupffer
cells, tissue degeneration and lymphocyte infiltration; c) rats treated with germanium L-cysteine
a-tocopherol showing normal shape like the control hepatic cells; d) irradiated group treated with
germanium L-cysteine a-tocopherol pre-irradiation showing signs of improvement towards normal
architecture.
CONCLUSIONS
The presented data provide evidence that treatment of rats with germanium L-cys-
teine a-tocopherol prior to whole body g-irradiation exerts a beneficial antioxidant protec-
tive effect through maintaining high blood levels of reduced glutathione and enhancing
the activities of antioxidant enzymes (CAT, SOD and GPx). It also offers considerable pro-
tection against radiation induced liver injury by inhibiting the chain reaction of membrane
lipid peroxidation. According to the foregoing results, we suggest that the radioresistant
effects of germanium L-cysteine a-tocopherol could be possibly used as radioprotector
against the treatment side effects induced by radiotherapy. The results of further experi-
ments that can be extended to other organs could be used for planning a more effective
therapy program combining radiation therapy and radioprotection.
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S A @ E T A K
Uloga kompleksa germanija s L-cysteinom i -tokoferolom kao stimulatora
antioksidativnog obrambenog sustava {takora izlo`enih gama-zra~enju
MAMDOUH M. ALI, EMAN NOAMAN, SHERIEN KAMAL, SAAED SOLIMAN i DINA A. ISMAIL
U radu je procjenjivan kompleks germanija s L-cisteinom i a-tokoferolom [germa-
nijev diklortetrakis (L-cisteinil-a-tokoferol amid) diklorid] kao za{titno sredstvo protiv
slobodnih radikala induciranih g-zra~enjem hepatotoksi~nosti. Mu`jacima {vicarskih al-
bino {takora davan je intraperitonealno kompleks germanija, u 6 sukcesivnih doza po 75
mg kg-1 tjelesne mase, posljednja doza dana je dvadeset minuta prije izlaganja cijelog
organizma jednokratnoj dozi g-ozra~ivanja od 6,5 Gy. U krvi i jetri pra}ena je razina li-
pidne peroksidacije (LPx), du{ikovog(II) oksida (NO), glutationa (GSH), aktivnost anti-
oksidativnih enzima glutation peroksidaze (GPx), superoksid dismutaze (SOD) i kata-
laze (CAT), te koli~ina ukupnih proteina u krvi, kolesterola, triglicerida i a-tokoferola.
Rezultati su pokazali da je primjena germanijevog kompleksa zna~ajno (p < 0,001) po-
bolj{ala koncentraciju jetrenih i krvnih LPx. Koncentracija GSH u jetri je zna~ajno po-
rasla (p < 0,001), dok se njegova razina u krvi nije zna~ajno promijenila. Koncentracija
NO u krvi i jetri zna~ajno se smanjila (p < 0,001). S druge strane, prethodna obrada s
kompleksom germanija normalizirala je aktivnost SOD, GPx i CAT u krvi i jetri u od-
nosu na ozra~enu skupinu. Istra`ivanja su tako|er pokazala zna~ajno smanjenje trigli-
cerida i kolesterola (p < 0,001) i zna~ajno pove}anje (p < 0,001) a-tokoferola i ukupnih
proteina u krvi. Te biokemijske promjene su povezane s izra`enim pobolj{anjem histo-
lo{kih promjena u odnosu na ozra~enu skupinu. Opisani kompleks germanija mogao bi
se kao antioksidativno sredstvo potencijalno upotrijebiti za sprije~avanje promjena uz-
rokovanih zra~enjem.
Klju~ne rije~i: germanijev L-cistein  -tokoferol kompleks, g-zra~enje, jetra, antioksidativni enzimi
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